NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

Mulholland has been pushing a different path. It aligns with that of the Australian MD with GBM. Existing agents including CIs combined with AI selected antigen based mRNA platforms (as best I can decode out of nebulous info). The tie in to melanoma is a clue.

Certainly a fair rebut, and what gives me pause in declaring this is definitely DCVax related.

The only thing is, those two items (the work you referenced and the Win-Glio program) seem like two separate initiatives. And the Win-Glio seems like what is more likely to be kicking off in May.

Nothing discernable, just an interesting development given the timing of all this information coming out.